Hemodialysis-Associated Infections: Treatment with Cephapirin
AUTOR(ES)
Berman, S. J.
RESUMO
Large doses of cephapirin (50 mg/kg) administered during the first and last half hours of routine hemodialysis produced effective antimicrobial serum concentrations for 48 h. Repetitive administration during five successive hemodialysis sessions did not result in accumulation or accelerated metabolism of cephapirin. Ten infectious episodes in nine patients were treated in this manner with good clinical results and no toxicity.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=352175Documentos Relacionados
- beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.
- Treatment of Pneumonia and Other Serious Bacterial Infections with Cephapirin
- Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.
- Neutropenia Associated with Cephapirin Therapy
- Nursing Care in Healthcare-Associated Infections: A Scoping Review
